Freeze Drying of Double Emulsions to Prepare Topotecan-Entrapping Liposomes Featuring Controlled Release

REFERENCES

• Abraham S. A., Edwards K., Karlsson G., Hudon N., Mayer L. D., Bally M. B. An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes. J. Control. Release 2004; 96: 449–461
   PubMed Web of Science ®Google Scholar
• Abraham S. A., Edwards K., Karlsson G., MacIntosh S., Mayer L. D., McKenzie C., et al. Formation of transition metal-doxorubicin complexes inside liposomes. Biochim. Biophys. Acta 2002; 1565: 41–54
   PubMed Web of Science ®Google Scholar
• Barenholz Y., Amselem S. Quality control assays in the development and clinical use of liposome-based formulations. Liposome ttechnology, G. Gregoriadis. CRC Press, Boca Raton, FL 1993; 2: 527–616
   Google Scholar
• Blume G., Cevc G. Molecular mechanism of the lipid vesicle longevity in vivo. Biochim. Biophys. Acta 1993; 1146: 157–168
   PubMed Web of Science ®Google Scholar
• Bouwstra J. A., Gooris G. S., Bras W., Talsma H. Small angle X-ray scattering: Possibilities and limitations in characterization of vesicles. Chem. Phys. Lipid 1993; 64: 83–98
   PubMed Web of Science ®Google Scholar
• Burke T. G. Chemistry of the camptothecins in the bloodstream. Drug stabilization and optimization of activity. Ann. N. Y. Acad. Sci. 1996; 803: 29–31
   PubMed Web of Science ®Google Scholar
• Burke T. G., Gao X. Stabilization of topotecan in low pH liposomes composed of distearoylphosphatidylcholine. J. Pharm. Sci. 1994; 83: 967–969
   PubMed Web of Science ®Google Scholar
• Burke T. G., Mishra A. K., Wani M. C., Wall M. E. Lipid bilayer partitioning and stability of camptothecin drugs. Biochemistry 1993; 32: 5352–5364
   PubMed Web of Science ®Google Scholar
• Cevc G. Lipid properties as a basis for membrane modeling and rational liposome design. Liposome technology, G. Gregoriadis. CRC Press, Boca Raton, FL 1993; 1: 1–36
   Google Scholar
• Charrois G. J. R., Allen T. M. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer. Biochim. Biophys. Acta 2004; 1663: 167–177
   PubMed Web of Science ®Google Scholar
• Cheung B. C., Sun T. H., Leenhouts J. M., Cullis P. R. Loading of doxorubicin into liposomes by forming Mn2+-drug complexes. Biochim. Biophys. Acta 1998; 1414: 205–216
   PubMed Web of Science ®Google Scholar
• Drummond D. C., Meyer O. M., Hong K., Kirpotin D., Papahadjopoulos D. Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors. Pharmacol. Rev. 1999; 51: 691–743
   PubMed Web of Science ®Google Scholar
• Fassberg J., Stella V. J. A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues. J. Pharm. Sci. 1992; 81: 676–684
   PubMed Web of Science ®Google Scholar
• Florence A. T., Whitehill D. The formulation and stability of multiple emulsions. Int. J. Pharm. 1982; 11: 277–308
   Web of Science ®Google Scholar
• Garbuzenko O., Barenholz Y., Priev A. Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer. Chem. Phys. Lipid 2005; 135: 117–129
   PubMed Web of Science ®Google Scholar
• Hertzberg R. P., Caranfa M. J., Hecht S. M. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme–DNA complex. Biochemistry 1989; 11: 4629–4638
   Google Scholar
• Johnston M. J. W., Semple S. C., Klimuk S. K., Edwards K., Eisenhardt M. L., Leng E.C., et al. Therapeutically optimized rates of drug release can be achieved by varying the drug-to-lipid ratio in liposomal vincristine formulations. Biochim. Biophys. Acta 2006; 1758: 55–64
   PubMed Web of Science ®Google Scholar
• Klibanov A. L., Maruyama K., Torchilin V. P., Huang L. Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes. FEBS Lett. 1990; 268: 235–237
   PubMed Web of Science ®Google Scholar
• Lasic D. D., Ceh B., Stuart M. C., Guo L., Frederic P. M., Barenholz Y. Transmembrane gradient driven phase transitions within vesicles: Lessons for drug delivery. Biochim. Biophys. Acta 1995; 1239: 145–156
   PubMed Web of Science ®Google Scholar
• Maurer-Spurej E., Wong K. F., Maurer N., Fenske D. B., Cullis P. R. Factors influencing uptake and retention of amino-containing drugs in large unilamellar vesicles exhibiting transmembrane pH gradients. Biochim. Biophys. Acta 1999; 1416: 1–10
   PubMed Web of Science ®Google Scholar
• Needham D., McIntosh T. J., Lasic D. D. Repulsive interactions and mechanical stability of polymer-grafted lipid membranes. Biochim. Biophys. Acta 1992; 1108: 40–48
   PubMed Web of Science ®Google Scholar
• New R. R. C. Characterization of liposomes. Liposomes: A practical approach, R. R. C. New. Oxford University Press, New York 1990a; 105–162
   Google Scholar
• New R. R. C. Preparation of liposomes. Liposomes: A practical approach, R. R. C. New. Oxford University Press, New York 1990b; 36–103
   Google Scholar
• Sharma A., Sharma U. S. Liposomes in drug delivery: Progress and limitations. Int. J. Pharm. 1997; 154: 123–140
   Web of Science ®Google Scholar
• Skalko N., Bouwstra J., Spies F., Stuart M., Frederik P. M., Gregoriadis G. Morphological observations on liposomes bearing covalently bound protein: Studies with freeze-fracture and cryo electron microscopy and small angle X-ray scattering techniques. Biochim. Biophys. Acta 1998; 1370: 151–160
   PubMed Web of Science ®Google Scholar
• Sternberg B. Freeze-fracture electron microscopy of liposomes. Liposome technology, G. Gregoriadis. CRC Press, Boca Raton, FL 1993; 1: 363–383
   Google Scholar
• Taggar A. S., Alnajim J., Anantha M., Thomas A., Webb M., Ramsay E., et al. Copper-topotecan complexation mediates drug accumulation into liposomes. J. Control. Release 2006; 114: 78–88
   PubMed Web of Science ®Google Scholar
• Takimoto C. H., Wright J., Arbuck S. G. Clinical applications of the camptothecins. Biochim. Biophys. Acta 1998; 1400: 107–119
   PubMed Web of Science ®Google Scholar
• Tardi P., Choice E., Masin D., Redelmeier T., Bally M., Madden T. D. Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models. Cancer Res. 2000; 60: 3389–3393
   PubMed Web of Science ®Google Scholar
• Ulukan H., Swaan P. W. Camptothecins: A review of their chemotherapeutic potential. Drugs 2002; 62: 2039–2057
   PubMed Web of Science ®Google Scholar
• Wang T., Deng Y., Geng Y., Gao Z., Zou J., Wang Z. Preparation of submicron unilamellar liposomes by freeze-drying double emulsions. Biochim. Biophys. Acta 2006; 1758: 222–231
   PubMed Web of Science ®Google Scholar
• van Winden E. C. A. Freeze-drying of liposmes: Theory and practice. Method Enzymol. 2003; 367: 99–110
   PubMed Web of Science ®Google Scholar
• Wolfe J., Bryant G. Freezing, drying and/or vitrification of membrane-solute-water systems. Cryobiology 1999; 39: 103–129
   PubMed Web of Science ®Google Scholar
• Wolkersa W. F., Oldenhof H., Tablina F., Crowe J. H. Preservation of dried liposomes in the presence of sugar and phosphate. Biochim. Biophys. Acta 2004; 1661: 125–134
   PubMed Web of Science ®Google Scholar
• Zhigaltsev I. V., Maurer N., Edwards K., Karlsson G., Cullis P. R. Formation of drug-arylsulfonate complexes inside liposomes: A novel approach to improve drug retention. J. Control. Release 2006; 110: 378–386
   PubMed Web of Science ®Google Scholar
• Zuidam N. J., van Winden E., de Vrueh R., Crommelin D. J. A. Stability, storage, and sterilization of liposomes. Liposomes: A practical approach, V. Torchilin, V. Weissig. Oxford University Press, New York 2003; 149–165
   Google Scholar